Clinical trial
Neuroenergetic Adaptations in Alzheimer's Disease: Implications on Amyloid Burden and Cognition.
NCT03999879 is registered in ClinicalTrials.gov with NYU Langone Health as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Neuroenergetic Adaptations in Alzheimer's Disease: Implications on Amyloid Burden and Cognition.
- Lead sponsor
- NYU Langone Health
- Phase
- Observational
- Overall status
- Completed
- Start date
- May 1, 2019
- Completion date
- February 24, 2023
- Enrollment
- 37 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.